Trivant Custom Portfolio Group, LLC Moderna, Inc. Transaction History
Trivant Custom Portfolio Group, LLC
- $171 Billion
- Q4 2024
A detailed history of Trivant Custom Portfolio Group, LLC transactions in Moderna, Inc. stock. As of the latest transaction made, Trivant Custom Portfolio Group, LLC holds 20 shares of MRNA stock, worth $677. This represents 0.0% of its overall portfolio holdings.
Number of Shares
20
Previous 120
83.33%
Holding current value
$677
Previous $8.02 Million
89.63%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding MRNA
# of Institutions
926Shares Held
252MCall Options Held
19MPut Options Held
24.3M-
Vanguard Group Inc Valley Forge, PA40.3MShares$1.36 Billion0.03% of portfolio
-
Baillie Gifford & CO38.9MShares$1.32 Billion1.28% of portfolio
-
Black Rock Inc. New York, NY25.6MShares$865 Million0.07% of portfolio
-
State Street Corp Boston, MA17.6MShares$595 Million0.03% of portfolio
-
Theleme Partners LLP London, X07.31MShares$247 Million20.37% of portfolio
About Moderna, Inc.
- Ticker MRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 391,200,000
- Market Cap $13.2B
- Description
- Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...